FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022403802> ?p ?o ?g. }

• W2022403802 endingPage "2075" @default.
• W2022403802 startingPage "2064" @default.
• W2022403802 abstract "Transitional cell carcinoma (TCC) is reported to be the fifth most common solid malignancy in the U.S. Although radical cystectomy will cure a substantial number of patients with minimally invasive TCC, many patients with deeply muscle-invasive or extravesical disease who are treated with radical cystectomy alone die of metastatic TCC, as do patients with metastatic disease. The differing clinical course and the limited value of established prognosticators make analysis of new molecular parameters of interest in predicting the prognosis of patients with bladder cancer, particularly those in high-risk groups who are at risk of disease progression and recurrence. In the current review, a comprehensive MEDLINE/PubMed search of articles pertaining to the biology of TCC from 1965 to the present was performed, as well as a bibliographic review of cross references. TCC follow the general concept of multistep carcinogenesis and proceed through two distinct genetic pathways responsible for generating different TCC morphologies, namely the inactivation of cyclin-dependent kinase inhibitors in low-grade TCC and early p53-mediated abnormalities in high-grade TCC. TCC progression correlates with genetic instability and the accumulation of collaborative genetic lesions mainly involving p53, retinoblastoma, and growth factors. The bulk of these data are derived from cases of localized/locally advanced disease and none are ready yet for routine clinical application; however, the current knowledge has led to the clinical testing of novel biologic observations in several important trials. Understanding of the molecular biology of advanced bladder cancer continues to improve. It is likely that in the new millennium, real breakthroughs in the identification and therapy of high-risk, poor-prognosis patients will come from an integration of molecular modalities in the clinical application. Cancer 2003;97(8 Suppl):2064–75. © 2003 American Cancer Society. DOI 10.1002/cncr.11289" @default.
• W2022403802 created "2016-06-24" @default.
• W2022403802 creator A5041126882 @default.
• W2022403802 creator A5066150739 @default.
• W2022403802 date "2003-04-01" @default.
• W2022403802 modified "2023-10-11" @default.
• W2022403802 title "Current understanding of the biology of advanced bladder cancer" @default.
• W2022403802 cites W1240286931 @default.
• W2022403802 cites W1820014750 @default.
• W2022403802 cites W1857682357 @default.
• W2022403802 cites W1893740135 @default.
• W2022403802 cites W1967171779 @default.
• W2022403802 cites W1967844100 @default.
• W2022403802 cites W1968115352 @default.
• W2022403802 cites W1973094198 @default.
• W2022403802 cites W1975172819 @default.
• W2022403802 cites W1981545318 @default.
• W2022403802 cites W1983918748 @default.
• W2022403802 cites W1983940323 @default.
• W2022403802 cites W1984557785 @default.
• W2022403802 cites W1994141277 @default.
• W2022403802 cites W1998543370 @default.
• W2022403802 cites W2001258296 @default.
• W2022403802 cites W2006994933 @default.
• W2022403802 cites W2009275723 @default.
• W2022403802 cites W2009771323 @default.
• W2022403802 cites W2010618512 @default.
• W2022403802 cites W2015050567 @default.
• W2022403802 cites W2015519364 @default.
• W2022403802 cites W2034713890 @default.
• W2022403802 cites W2037179040 @default.
• W2022403802 cites W2039082157 @default.
• W2022403802 cites W2044573147 @default.
• W2022403802 cites W2045292004 @default.
• W2022403802 cites W2046668563 @default.
• W2022403802 cites W2049273954 @default.
• W2022403802 cites W2049794563 @default.
• W2022403802 cites W2050740674 @default.
• W2022403802 cites W2052574478 @default.
• W2022403802 cites W2054708937 @default.
• W2022403802 cites W2055189320 @default.
• W2022403802 cites W2055795977 @default.
• W2022403802 cites W2057967430 @default.
• W2022403802 cites W2072894518 @default.
• W2022403802 cites W2074070420 @default.
• W2022403802 cites W2078828163 @default.
• W2022403802 cites W2086961150 @default.
• W2022403802 cites W2088708117 @default.
• W2022403802 cites W2092587910 @default.
• W2022403802 cites W2093199751 @default.
• W2022403802 cites W2093213867 @default.
• W2022403802 cites W2094952890 @default.
• W2022403802 cites W2109609879 @default.
• W2022403802 cites W2114306533 @default.
• W2022403802 cites W2119682635 @default.
• W2022403802 cites W2124441131 @default.
• W2022403802 cites W2140858291 @default.
• W2022403802 cites W2143224158 @default.
• W2022403802 cites W2154027407 @default.
• W2022403802 cites W2155560889 @default.
• W2022403802 cites W2163565167 @default.
• W2022403802 cites W2164796201 @default.
• W2022403802 cites W2169256297 @default.
• W2022403802 cites W2171237326 @default.
• W2022403802 cites W2223163871 @default.
• W2022403802 cites W2326413988 @default.
• W2022403802 cites W2401330586 @default.
• W2022403802 cites W2402166800 @default.
• W2022403802 cites W2409348391 @default.
• W2022403802 cites W4239454621 @default.
• W2022403802 cites W4245635197 @default.
• W2022403802 cites W91971561 @default.
• W2022403802 doi "https://doi.org/10.1002/cncr.11289" @default.
• W2022403802 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12673698" @default.
• W2022403802 hasPublicationYear "2003" @default.
• W2022403802 type Work @default.
• W2022403802 sameAs 2022403802 @default.
• W2022403802 citedByCount "53" @default.
• W2022403802 countsByYear W20224038022012 @default.
• W2022403802 countsByYear W20224038022013 @default.
• W2022403802 countsByYear W20224038022014 @default.
• W2022403802 countsByYear W20224038022015 @default.
• W2022403802 countsByYear W20224038022016 @default.
• W2022403802 countsByYear W20224038022017 @default.
• W2022403802 countsByYear W20224038022020 @default.
• W2022403802 countsByYear W20224038022022 @default.
• W2022403802 crossrefType "journal-article" @default.
• W2022403802 hasAuthorship W2022403802A5041126882 @default.
• W2022403802 hasAuthorship W2022403802A5066150739 @default.
• W2022403802 hasBestOaLocation W20224038021 @default.
• W2022403802 hasConcept C104317684 @default.
• W2022403802 hasConcept C121608353 @default.
• W2022403802 hasConcept C126322002 @default.
• W2022403802 hasConcept C143998085 @default.
• W2022403802 hasConcept C2775910329 @default.
• W2022403802 hasConcept C2776577112 @default.
• W2022403802 hasConcept C2778065480 @default.
• W2022403802 hasConcept C2779134260 @default.

• next